The chronopharmacokinetics and chronopharmacodynamics of cisplatin were stu
died in a mouse model to reveal the mechanisms of dosing time-dependent nep
hrotoxicity induced by daily administration. Chronotoxicity was tested by d
aily intraperitoneal injections of cisplatin (6 mg kg(-1)) for 5 days at fo
ur time points (04 00, 10 00, 16 00 and 22 00 h) in BALB/c mice (n = 6 in e
ach group). After following the changes in body weight, serum concentration
s of blood urea nitrogen (BUN) and creatinine obtained on day 6 were compar
ed.
The results showed diurnal variations in cisplatin toxicity, with the 04 00
and 16 00 h time points the best and the worst, respectively, We then meas
ured platinum concentrations in blood, liver and kidney and compared the re
sults of the 04 00 and 16 00 h groups (n = 4 in each group). Kidney sensiti
vity to cisplatin alone, lipopolysaccharide (LPS) alone, cisplatin with LPS
and saline (control) were also measured using a tissue culture system (a m
easurement system of interleukin-6 (IL-6) production) between the 04 00 and
the 16 00 h groups (n = 4 in each group). These results showed no signific
ant difference in platinum accumulation between the two groups. IL-6 produc
tion was higher in the 16 00 h group than in the 04 00 h group after saline
injection alone (P < 0.05). Cisplatin treatment alone did not increase IL-
6 production. However, IL-6 levels were markedly augmented by cisplatin wit
h LPS.
In conclusion, chrononephrotoxicity induced by daily cisplatin administrati
on does not only depend on cisplatin accumulation, but might also depend on
kidney sensitivity to diurnal variations in inflammatory reaction without
direct cisplatin toxicity.